Skip to main content
    S

    Synlogic Inc (SYBX)

    Official site

    BIOTECHNOLOGY

    $1.02
    -0.04 (-3.77%)

    Last updated: Oct 14, 2026 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    76%(25/33)
    Avg Surprise
    +18.57%
    Streak
    3 Q
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 13
    		$-0.19N/AN/ABeat-1800.0%
    Jun 25
    Reported Aug 7
    		$-0.04$0.00N/ABeat-108.5%
    Mar 25
    Reported May 12
    		$-0.06$0.00N/ABeat+97.7%
    Dec 24
    Reported Mar 6
    		$0.85$-0.10+950.00%Beat+149.7%
    Sep 24
    Reported Nov 12
    		$-0.01N/A+94.44%Beat+99.6%
    Jun 24
    Reported Aug 8
    		$0.47$-0.51+192.16%Beat+323.8%
    Mar 24
    Reported May 14
    		$-2.60$-0.82-217.07%Miss-1030.4%
    Dec 23
    Reported Mar 19
    		$-1.71$-0.97-76.29%Miss-612.5%
    Sep 23
    Reported Nov 9
    		$-2.57$-2.67+3.75%Beat-928.0%
    Jun 23
    Reported Aug 10
    		$-0.21$-0.24+12.50%Beat+4.5%
    Mar 23
    Reported May 11
    		$-0.23$-0.23+0.00%Beat-4.5%
    Dec 22
    Reported Mar 29
    		$-0.24$-0.25+4.00%Beat-14.3%
    Sep 22
    Reported Nov 10
    		$-0.25$-0.23-8.70%Miss+13.8%
    Jun 22
    Reported Aug 11
    		$-0.22$-0.23+4.35%Beat+21.4%
    Mar 22
    Reported May 12
    		$-0.22$-0.23+4.35%Beat+38.9%
    Dec 21
    Reported Mar 17
    		$-0.21$-0.26+19.23%Beat+44.7%
    Sep 21
    Reported Nov 10
    		$-0.29$-0.29+0.00%Beat+19.4%
    Jun 21
    Reported Aug 12
    		$-0.28$-0.31+9.68%Beat+36.4%
    Mar 21
    Reported May 13
    		$-0.36$-0.39+7.69%Beat+21.7%
    Dec 20
    Reported Mar 25
    		$-0.38$-0.40+5.00%Beat-2.7%
    Sep 20
    Reported Nov 5
    		$-0.36$-0.47+23.40%Beat+7.7%
    Jun 20
    Reported Aug 6
    		$-0.44$-0.46+4.35%Beat+2.2%
    Mar 20
    Reported May 8
    		$-0.46$-0.43-6.98%Miss+9.8%
    Dec 19
    Reported Mar 12
    		$-0.37$-0.44+15.91%Beat+21.3%
    Sep 19
    Reported Nov 12
    		$-0.39$-0.48+18.75%Beat+9.3%
    Jun 19
    Reported Aug 8
    		$-0.45$-0.49+8.16%Beat+23.7%
    Mar 19
    Reported May 9
    		$-0.51$-0.54+5.56%Beat+7.3%
    Dec 18
    Reported Mar 12
    		$-0.47$-0.54+12.96%Beat+36.5%
    Sep 18
    Reported Nov 13
    		$-0.43$-0.63+31.75%Beat+74.1%
    Jun 18
    Reported Aug 8
    		$-0.59$-0.53-11.32%Miss+80.8%
    Mar 18
    Reported May 15
    		$-0.55$-0.73+24.66%Beat+34.5%
    Dec 17
    Reported Mar 20
    		$-0.74$-0.79+6.33%Beat+49.7%
    Sep 17
    Reported Nov 13
    		$-1.66$-0.50-232.00%Miss-
    Jun 17
    Reported Aug 4
    		$-3.08$-0.77-300.00%Miss-
    Mar 17
    Reported May 9
    		$-0.84$-0.70-20.00%Miss-
    Dec 16
    Reported Mar 14
    		$-1.47$-1.99+26.13%Beat-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/Equity0.00xInterest CoverageN/A
    Current Ratio9.19xQuick Ratio9.19x
    Trading Statistics
    BetaN/AAvg Volume30.37K
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$1.08
    SMA 20$1.12
    SMA 50$1.17
    SMA 200$0.83
    EMA 10$1.08
    EMA 20$1.11
    EMA 50$1.09
    EMA 200$0.98

    MACD

    Line: -0.03Signal: -0.02Hist: -0.01

    ADX

    ADX: 20.6+DI: 17.1-DI: 42.5

    Aroon & PSAR

    Aroon Up4.0
    Aroon Down100.0
    PSAR$1.11

    Bollinger Bands

    Upper Band$1.20
    Lower Band$1.03
    %B Position1482%(Upper)
    Band Width-0.08

    RSI (14-Day)

    Oversold
    29.8

    Momentum Oscillators

    Stoch %KN/A
    Stoch %D8.3
    Williams %R-100.0
    ROC (10d)-8.9%
    Momentum-0.10
    CCI (20d)-189.7
    MFI (14d)12.3

    Volatility Measures

    ATR (14d)$0.03(2.8%)
    StdDev (20d)0.04
    Hist Vol28.8%(Moderate)

    Volume Flow

    VWAP$1.03
    OBV588.8K
    AD Line-5.5M
    CMF (20d)-0.215

    Volume Metrics

    Avg Vol (20d)33.1K
    Vol Ratio0.1x(Low)
    VWMA (20d)$1.11

    Pivot Points

    R3$1.09
    R2$1.09
    R1$1.07
    Pivot Point$1.07
    S1$1.05
    S2$1.05
    S3$1.03

    Advanced Oscillators

    TSI-21.06
    Ultimate Osc19.5
    KST-82.71

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$0$0$0$0$0$0$0$0$0$8,000$2.77M$393,000
    Cost of Revenue$0$0N/A$0$0$0N/A$0$0$0$1.27M$0
    Gross Profit$0$0N/A$0$0$0N/A$0$0$8,000$2.77M$393,000
    Operating Expenses$1.00M$1.32M$1.34M$991,000$777,000$898,000$1.78M$748,000$-419,000$38.85M$13.41M$13.02M
    R&D$0$49,000$27,000$8,000$-14,000$22,000$-10,000$-713,000$2.20M$7.68M$10.14M$9.62M
    SG&A$828,000$1.06M$1.03M$818,000$800,000$836,000$1.40M$1.17M$1.18M$2.88M$3.27M$3.40M
    Operating Income$-1,012,000$-1,319,000$-1,342,000$-991,000$-777,000$-898,000$-1,776,000$-748,000$419,000$-38,845,000$-10,641,000$-12,623,000
    Interest Income$120,000$128,000$151,000$175,000$181,000$188,000$224,000$254,000$394,000$553,000$675,000$549,000
    Interest Expense$0$0$0$1.31M$0$0$24.54M$0$0$0$7.88M$0
    Income Before Tax$-543,000$681,000$1.82M$-2,301,000$-529,000$317,000$-26,320,000$-117,000$3.08M$0$-18,523,000$-12,075,000
    Income Tax Expense$0$0$0$0$0$0$0$0$5,000$0$0$3,000
    Net Income$-543,000$681,000$1.51M$-2,301,000$-529,000$317,000$-714,000$-117,000$3.08M$-25,606,000$-18,525,000$-12,078,000
    EBITDA$-663,000$553,000$1.36M$-2,476,000$-710,000$129,000$-938,000$-371,000$2.68M$-26,043,000$-19,101,000$-12,219,000
    EBIT$-663,000$553,000$1.36M$-2,476,000$-710,000$129,000$-938,000$-371,000$2.69M$-26,159,000$-19,198,000$-12,624,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about SYBX

    News

    Synlogic and Caldera Therapeutics Announce Merger and $278 Million Private Placement

    Synlogic, Inc. and Caldera Therapeutics have announced a merger alongside a $278 million private placement. Mintz advised Synlogic, Fenwick & West advised Caldera Therapeutics...

    Global Legal Chronicle•8/3/26•Bullish

    Mintz Advises Synlogic on Merger with Caldera Therapeutics and $278 Million Private Placement Financing

    Mintz advised Synlogic, Inc. on its definitive merger agreement with Caldera Therapeutics, Inc., forming a new company, Caldera Therapeutics, Inc....

    Mintz•7/30/26•Bullish

    Caldera, Synlogic Reverse Merge To Develop CLD-423 In Inflammatory Bowel Disease

    Caldera and Synlogic have announced a reverse merger to advance the development of CLD-423, a therapeutic candidate for Inflammatory Bowel Disease. The merger aims to combine the resources and expertise of both companies...

    insights.citeline.com•7/30/26•Bullish

    Synlogic and Caldera sign merger agreement

    Synlogic and Caldera Therapeutics have announced a definitive merger agreement, forming a combined company that will be a 100%-owned subsidiary of Caldera Therapeutics...

    Pharmaceutical Technology•7/30/26•Bullish

    Synlogic (SYBX) holder NEA reports 25% stake and backs Caldera merger

    New Enterprise Associates 14, a major shareholder in Synlogic, has updated its beneficial ownership report, confirming a 25.0% stake in the company. NEA 14 supports Synlogic's planned merger with Caldera Therapeutics...

    Stock Titan•7/30/26•Somewhat-Bullish

    SYBX Valuation and Fair Value

    P/B
    1.1x
    See GNG's fair value

    SYBX Competitors

    CompanyTicker
    Anebulo Pharmaceuticals IncANEB
    Tharimmune Inc.THAR
    GT Biopharma IncGTBP
    Pluri Inc.PLUR
    Femasys IncFEMY
    In8bio IncINAB
    Biofrontera IncBFRI
    Passage Bio IncPASG

    Sector: Healthcare

    SYBX Earnings: Beat Rate and Next Report

    Beat rate
    4 of 8 quarters (50.0%)
    Average surprise
    157.8%

    Frequently Asked Questions About SYBX

    Does SYBX pay dividends?

    Synlogic Inc (SYBX) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with S

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In